Partner Dan Shores will present on "Navigating the IP Landscape for Lipid Nanoparticle Technology in the mRNA Space" at the LNP Formulation & Process Development Summit taking place April 12-14, 2022, in Boston, Massachusetts.
Dan's session, being held during the opening address on the second day of the conference, April 14, will cover a brief history of intellectual property in the space, the current IP and competitive landscape for LNP technology, strategies for freedom to operate, design-around, and licensing, and IP protection strategies for new innovations.
The inaugural LNP Formulation & Process Development Summit is the industry’s first forum dedicated to bringing together drug developers within the LNP field to share the latest scientific breakthroughs on formulation and process development.
